On June 29, 2021, BenTre Pharmaceutical Joint Stock Company completed the increase of ownership ratio in Yen Bai Pharmaceutical Joint Stock Company. After the deal, BenTre Pharmaceutical Joint Stock Company owns 85.9% charter capital of Yen Bai Pharmaceutical Joint Stock Company.